IPH-4201

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameIPH-4201
Drug Alias NameFAPP-targeting mAb (Universite de la Mediterranee/INSERM)feto-acinar pancreatic protein-targeting monoclonal antibodies (Innate Pharma)feto-acinar pancreatic protein-targeting monoclonal antibodies (Universite de la Mediterranee/INSERM)mAb-J28FAPP-targeting mAb (Innate Pharma) +[7] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCholesterol ester modulators
TargetsCholesterol ester
Therapy Area/IndicationsPancreatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAix-Marseille University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInsermInnate Pharma SAAix-Marseille University
Active IndicationsN/A
Inactive IndicationsPancreatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A